Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases. - EP2763982
EP2763982
- Application Number
- EP12766997A
- Filing Date
- Oct 4, 2012
- Status
- No Opposition Filed Within Time Limit
- Nov 16, 2018
- Grant Date
- Jan 10, 2018
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2763982B1 was granted to Bayer on Jan 10, 2018 following the initial filing on Oct 4, 2012 under the application number EP12766997A . The current legal status of the patent is No Opposition Filed Within Time Limit.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents